中文
Company News
- Scale-Up Facilities and Leading Expertise Drive Commercial Fermentation Progress 5/24/2022
- Source the Best PseudoUridines at Industry-Renowned Exhibitions 5/23/2022
- Carbohydrates of BOC Sciences Reveal Myriad Possibilities for Therapeutics 5/20/2022
- BOC Sciences Officially Releases the Final Invitation to Renowned Pharma Conferences in Ma... 5/19/2022
- siRNA Drug Delivery Platform of BOC RNA Speeds Up Disease Treatment Researc 1/14/2022
- BOC Sciences Webinar: Targeting RNA Structure as a Therapeutic Strategy 12/27/2021
- BOC Sciences Proudly Declares High PseudoUridine Productivity 12/17/2021
- BOC Sciences' Exhibition at TIDES USA 2021 Shows Its Strong ... 12/14/2021
- BOC Sciences Provides PseudoUridines for Vaccine R&D 12/9/2021
- BOC Sciences Adds Phosphoramidites to Its Nucleotide Product Portfolio for&... 11/30/2021
- BOC RNA Expands Its Oligo Synthesis Services for Biomedical Research 11/26/2021
- BOC Sciences Supplies Novel Antibody-Drug Conjugates to Assist in Drug... 11/23/2021
- BOC Sciences Expands Amino Acid Synthesis Services to Promote Peptide Drug R&D 10/29/2021
- BOC Sciences Optimizes Production and Development of Microbial Metabolites 10/22/2021
- BOC Sciences Establishes Optimal Route of APIs Production Through Microbial ... 9/29/2021
- BOC Sciences Upgrades Its Supply Chain of Amino Acid and Pep... 9/16/2021
- BOC Sciences Offers Pseudouridine and Its Derivatives for RNA Improvement 8/30/2021
- BOC Sciences Provides Pseudouridine and Its Derivatives for Pharmaceutical Manufacturing a... 7/30/2021
- BOC Sciences cGMP Manufacturing Platform Provides Pseudouridine in Response to COVID-19 mR... 7/12/2021
- BOC Sciences cGMP Manufacturing Platform Provides Pseudouridine in Response to COVID-19 mR... 7/9/2021